1. Oracle's Q2 sales missed analyst estimates, impacting investor sentiment negatively. 2. Despite record backlog of $523 billion, shares fell nearly 14%. 3. Analysts show mixed feelings, with most rating Oracle as a 'buy'. 4. Concerns persist regarding reliance on a few large customers. 5. Debt concerns may limit short-term gains, but long-term growth prospects remain.